絞り込み

16645

広告

3406件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Comparison of dabigatran, rivaroxaban and apixaban for effectiveness and safety in atrial fibrillation; a nationwide cohort study.

Ischemic Stroke with Protein S Deficiency Treated by Apixaban.

Atrial fibrillation: an update on management.

Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty: The FOXTROT Randomized Clinical Trial.

Bleeding in anticoagulated patients with atrial fibrillation: practical considerations.

Pain in the hip: Spontaneous retroperitoneal hemorrhage in an elderly patient on apixaban.

Regional variation in clinical characteristics and outcomes in patients with atrial fibrillation: Findings from the ARISTOTLE trial.

Patient Preferences for Nonvitamin K Antagonist Oral Anticoagulants in Stroke Prevention: A Multicountry Discrete Choice Experiment.

Rivaroxaban Versus Apixaban in Nonvalvular Atrial Fibrillation Patients with End-Stage Renal Disease or Receiving Dialysis.

The real world use of combined P-glycoprotein and moderate CYP3A4 inhibitors with rivaroxaban or apixaban increases bleeding.

Risk of Osteoporosis in Patients With Atrial Fibrillation Using Non-Vitamin K Antagonist Oral Anticoagulants or Warfarin.

Temporal Trends in the Practice Pattern for Venous Thromboembolism in Japan: Insight From JROAD-DPC.

A Systematic Review of Network Meta-Analyses and Real-World Evidence Comparing Apixaban and Rivaroxaban in Nonvalvular Atrial Fibrillation.

Using the PCI-IS Method to Simultaneously Estimate Blood Volume and Quantify Nonvitamin K Antagonist Oral Anticoagulant Concentrations in Dried Blood Spots.

Direct oral anticoagulants and warfarin in patients with cirrhosis: a comparison of outcomes.

Factors IX, XI, and XII: potential therapeutic targets for anticoagulant therapy in atherothrombosis.

European Stroke Organisation Guideline on Reversal of Oral Anticoagulants in Acute Intracerebral Haemorrhage.

Incidence of Deep Venous Thrombosis Associated With Proximal Hamstring Rupture.

Cost-Effectiveness Analysis of Oral Anticoagulants in Stroke Prevention among Patients with Atrial Fibrillation in Taiwan.

Safety outcomes of apixaban in patients with nonvalvular atrial fibrillation and severe renal impairment.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります